Venture Capital Deals
CAN Capital, an online provider of small business capital, has raised $33 million in new VC funding. Meritech Capital Partners led the round, and was joined by Ribbit Capital, QED Investors and return backer Accel Partners. www.cancapital.com
Aquion Energy Inc., a Pittsburgh-based developer of water-based sodium ion batteries, has raised $20 million in additional Series D funding, bringing the round total to $55 million. New backers include Bill Gates, Yung's Enterprise, Tao Invest, Bright Capital and Gentry Venture Partners. Return backers include Kleiner Perkins Caufield & Byers, Foundation Capital, and Advanced Technology Ventures. www.aquionenergy.com
Avelas Biosciences, a San Diego-based startup focused on visualizing cancerous lymph nodes in breast cancer patients, has raised $6.85 million in Series B funding. Existing backer Avalon Ventures led the round, and was joined by Torrey Pines Investment and WuXi AppTec. www.avelasbio.com
Private Equity Deals
Affinity Equity Partners has entered into exclusive negotiations to acquire juice bar chain operator Retail Zoo from The Riverside Company, according to The Australian. UBS is managing the process. www.boostjuice.com.au
ComplexCare Solutions Inc., a New York-based provider of healthcare payer services, has raised $40 million in growth equity funding from Warburg Pincus. www.complexcaresolutions.com
Macquarie Group, TPG Capital and Vitol Group are considering bids for some of Royal Dutch Shell's Australian downstream operations, according to Bloomberg. The Amazon Sales could be valued at around $2.7 billion. www.shell.com
IPOs
Flexion Therapeutics Inc., a Woburn, Mass.-based developer of therapeutics for musculoskeletal disorders, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol FLXN, with BMO Capital Markets serving as lead underwriter. Shareholders include Versant Ventures (29.76% pre-IPO stake), Sofinnova Capital (19.25%), Pfizer Inc. (17.32%), 5AM Ventures (15.52%) and Novo AS (11.2%). www.flexiontherapeutics.com
, an Emeryville, Calif.-based developer of biomarker platform technology, has filed for a $48.3 million IPO. It plans to trade on the Nasdaq under ticker symbol KNMD, with H.C. Wainwright & Co. serving as lead underwriter. www.kinemed.com
OTHER DEALS
Glori Energy Inc., a Houston, Texas-based provider of biotech solutions to increase recovery from mature oil wells, is going public via a $185 million reverse merger with Infinity Cross Border Acquisition Corp. (Nasdaq: INXB). Infiniy's sponsors are Infinity Group and Hicks Equity Partners, while Glori Energy backers include GTI Ventures (18.5% stake), Oxford Bioscience Partners (19%), The Ozmest Group (18.3%), Kleiner Perkins Caufield & Byers (15.7%), Malaysian Life Sciences Capital Fund (13.5%), Energy Technology Ventures (6.9%), Gentry Venture Partners and Advantage Capital Partners. www.glorioil.com
Sign up for Dan Primack's daily email newsletter on deals and deal-makers: GetTermSheet.com
No comments:
Post a Comment